Adrian Covic, Mehmet Kanbay, Edgar V. Lerma, editors
1 online resource
Includes bibliographical references and index
Epidemiology/Prevalence of Dyslipidemia in the General Population and in Patients with Chronic Kidney Disease -- Lipid Nephrotoxicity: New Concept for an Old Disease -- Hyperlipidemia as a Risk Factor for Progression of CKD in Nondiabetics -- Hyperlipidemia as a Risk Factor for Progression of CKD in Nondiabetics -- How Lipid-Lowering Agents Work: The Good, the Bad, and the Ugly -- CVD in CKD: Focus on the Dyslipidemia Problem -- The CKD Patient with Dyslipidemia -- Review of Clinical Trials Pertaining to Dyslipidemias in CKD -- Pharmacokinetics of Lipid-Lowering Medications in Chronic Kidney Disease -- Non-statin Therapies for CKD with Dyslipidemia -- Dyslipidemia in Dialysis -- Dyslipidemia in the Kidney Transplant Patient -- Dyslipidemia in Nephrotic Syndrome -- Dyslipidemias in the Pediatric Chronic Kidney Disease Patient -- Dyslipidemias in the Geriatric Chronic Kidney Disease Patients -- Apheresis Methods in Hyperlipidemias -- Review of Current Guidelines: National Cholesterol Education Program and Kidney Disease Outcomes Quality Initiative as They Apply to CKD with Dyslipidemias
0
Dyslipidemia in chronic kidney disease is a common clinical problem and growing in prevalence. With the recent publication of clinical practice guidelines on the management of lipid related disorders in patients affected by chronic kidney disease, an up-to-date and comprehensive resource of evidence-based literature is needed. Dyslipidemias in Kidney Disease captures the growing body of information on this subject matter. This book presentsthe latest clinical evidence and management guidance for patients of various demographics and stages of chronic kidney disease. Written for the nephrologist community, as well as cardiologists and general practitioners, this guide will provide practical knowledge and fill a much needed void in the literature